Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
A novel non-invasive method for using carbon-13 magnetization transfer effects to determine and evaluate in vivo aspartate transaminase (AST) activity and levels in an organ, as a biomarker of disease and certain neurological disorders. More
Neomics has found a very promising target, AIMP2/AIMP2-DX2 for siRNA therapy application to tumoric lung cancer cells and we intend to focus the remaining resources on developing through clinical trials, the siRNA therapy as a first priority More
Dendritic cell (DC) generation and manipulation technology for the development of a cancer vaccine and rheumatoid arthritis (RA) therapeutics. Based on DC manipulating technology, Creagene is developing DC-based cancer vaccines against renal cell car More
A cancer therapy and diagnostic that utilizes a variation of "Boron Neutron Capture Therapy" to deliver intense, short-lived, therapeutic doses of radiation specifically to active tumor sites. More
The technology describes the humanization of a murine anti-carcinoma antibody CC49 which has been shown to react with Tumor Associated Glycoprotein 72 (TAG-72), an antigen which is expressed on human breast, ovarian, colorectal, and other carcinomas. More
Aerosolized immunogenic compositions that may prove useful for vaccination against respiratory infections and may provide a platform for generating mucosal antibody responses against other pathogens. More
Methods and assays which may be used to diagnose and follow the progression of cancers associated with c-Met expression More
Adrenomedullin peptides and antibodies, which would be useful in the development of a therapeutic or for diagnostics use More
This complex has potential for use a large number of treatments where drug delivery is needed and could be used worldwide. More
Methods and compositions for making and using functionalized sugars More
Related Reports
Market Research Reports provided by reports.innovaro.com
Nov 2010 - 26 pages - $125
Dec 2010 - 19 pages - $99
Aug 2009 - $15,200
Aug 2010 - $15,200
Nov 2009 - 160 pages - $2,265
Jun 2011 - 34 pages - $125
Mar 2010 - $5,700
Feb 2008 - $2,500
Mar 2011 - 120 pages - $3,500
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us